… receiving ECMO (23). The aims of this paper were to describe the population PK of
piperacillin and tazobactam in critically ill adults receiving ECMO with and without RRT and to …

… first population PK study of piperacillin in critically ill patients in … the probability of PK/PD
target attainment in critically ill patients, an … with a lower probability of PK/PD target attainment. A …

… population pharmacokinetics of piperacillin when infused continuously in critically ill patients…
For this analysis, 270 plasma samples from 110 critically ill patients receiving piperacillin …

… was to characterize tazobactam PK in a cohort of critically ill patients with Gram… population
PK modeling approach. Currently, a population model that characterizes the pharmacokinetics …

… commonly prescribed to critically ill patients placed on … pharmacokinetic data in critically ill
patients undergoing CKRT to better understand pharmacokinetics of pip-tazo in this population…

… The aim of this study was to assess the PK of piperacillin in critically ill patients treated
with CI. A population PK model was developed to identify patient covariates and evaluate the …

… regarding the population pharmacokinetics of tazobactam in … population pharmacokinetics
of piperacillin and tazobactam … a pediatric intensive care unit (ICU). Additionally, we evaluated …

… of both piperacillin and tazobactam in critically ill patients. … population PK model of
piperacillin/tazobactam that is suitable for critically ill Korean adult patients, including those receiving …

… therapy (CRRT), may alter the pharmacokinetics of piperacillin-tazobactam. We aimed to …
a population pharmacokinetic model of piperacillin-tazobactam in critically ill patients during …

… piperacillin-tazobactam and provides comprehensive data on current dosing strategies while
identifying significant covariates in critically ill patients… care unit OR critically ill). Additionally…